Cubiró, X <br/><br/>
The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months' Evolution and Prior Immunosuppressive Treatment.  [electronic resource] 

 -  Actas dermo-sifiliograficas  May 2019 
 - 289-296 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2173-5778 
<br/><br/><label>Standard No.: </label>10.1016/j.ad.2018.09.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Allergic Agents--therapeutic use<br/>Chronic Disease<br/>Female<br/>Histamine H1 Antagonists--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Omalizumab--therapeutic use<br/>Pragmatic Clinical Trials as Topic<br/>Registries<br/>Remission Induction<br/>Retrospective Studies<br/>Treatment Outcome<br/>Urticaria--drug therapy<br/>Young Adult